Mr. Culley joined Lineage as Chief Executive Officer in September 2018. Prior to joining Lineage, Mr. Culley served from August 2017 to September 2018 as interim Chief Executive Officer at Artemis Therapeutics, Inc. (ATMS). Mr. Culley previously served as Chief Executive Officer of Mast Therapeutics, Inc. (MSTX), from 2010, and was also a member of […]

NeuroRx has reported that preliminary results from its Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed it reduced hospital stay among patients with respiratory failure due to critical Covid-19. Zyesami is a synthetic form of human Vasoactive Intestinal Peptide (VIP). The study was carried out in partnership with Relief Therapeutics and had 203 patients. […]

US company COVAXX has announced positive interim data from Phase I clinical trial of its Covid-19 vaccine candidate, UB-612, conducted in Taiwan. UB-612 is a multitope peptide-based vaccine designed to stimulate both B and T-cell arms of the immune system to fight against SARS-CoV-2. It also permits for successful cold chain management with existing infrastructure […]